Hims said Tuesday that it "looks forward to engaging with the FDA." "Our website and our customer-facing materials note that compounded treatments are not approved or evaluated by the FDA," the company said in a statement
The effect seems to be related to the GLP-1 receptor agonists potency for weight loss
KEY FEATURES GLP-1 Shot Tracker Easily log your weekly shots of Semaglutide, Tirzepatide, or other GLP-1 medications
Tirzepatide remains in blue and Retatrutide remains in red-- not only is the total fat burning substantially larger, yet the majority of weight reduction is pure fat
Adopting these lifestyle changes may help you achieve your weight loss goals while on weight loss medication, help you maintain your weight loss if you decide to stop treatment, and help to improve your overall health
Current users report several significant lifestyle shifts since starting GLP-1 medications